The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with FCS - Sorbonne Université Access content directly
Conference Papers Year : 2018

The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with FCS

Daniel Gaudet
  • Function : Author
Andres Digenio
  • Function : Author
Veronica Alexander
  • Function : Author
Marcello Arca
  • Function : Author
Alan Jones
  • Function : Author
Erik Stroes
  • Function : Author
Jean Bergeron
  • Function : Author
Fernando Civeira
  • Function : Author
Linda Hemphill
  • Function : Author
Dirk Blom
  • Function : Author
Joann Flaim
  • Function : Author
Steven Hughes
  • Function : Author
Richard Geary
  • Function : Author
Sotirios Tsimikas
  • Function : Author
No file

Dates and versions

hal-03969811 , version 1 (02-02-2023)

Identifiers

Cite

Daniel Gaudet, Andres Digenio, Veronica Alexander, Marcello Arca, Alan Jones, et al.. The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with FCS. International Symposium on Atherosclerosis (ISA), Jun 2018, Toronto, Canada. pp.14-15, ⟨10.1016/j.atherosclerosissup.2018.04.042⟩. ⟨hal-03969811⟩
2 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More